Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Idebenone for the Preventive Treatment of Migraine — Stella

Home/Migraine Disorders/Idebenone for the Preventive Treatment of Migraine

View on ClinicalTrials.gov

Recruiting

Back to Migraine Disorders trials

Idebenone for the Preventive Treatment of Migraine

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Kaiming Liu, Hangzhou, Zhejiang

Key details

Phase

Large-scale testing

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~180 participants

Started

December 2021

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.